PATH is delighted to invite you to a webinar!
Webinar topic: Application of Next-Generation Sequencing for Vaccine Development and Testing
Description: Intended for Developing Country Vaccine Manufacturers (DCVM), this Webinar will provide up-to-date information and guidance from subject matter experts on Next-Gen Sequencing (NGS) methodology, validation, regulatory expectations, and controls. This session will also provide real-world NGS application in the form of two case studies and will end with a panel discussion with regulatory experts.
If you are interested in attending, please register for this webinar by filling out this short registration form (estimated time to complete: 2 minutes).
Dates: Sept 17 and 18th, 2025 (3 hours each day) – 6-9am EST
Goal: Discuss the practical applicability of NGS for vaccine development and testing for use by the Developing Countries Vaccine Manufacturers (DCVMs)
Topics: The program will include presentations by subject matter experts on:
- NGS process overview
- NGS validation and regulatory expectations
- Control samples and data review
- Case study 1: Adventitious Agent testing
- Case study 2: NGS testing for replacements of animal neurovirulent testing
A calendar webinar invitation will also be sent out shortly.
Should you have any questions or issues accessing the registration form, calendar invitation, or assistance with anything else, please do not hesitate to reach out to Laura McCormick at lmccormick@path.org.
